Fabrice Jardin

13PUBLICATIONS
44CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesNatural language processing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 01, 2026
PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma.

|Nov 03, 2025
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials.

Valentin Letailleur, Isabelle Chaillol, Fanny Cherblanc

|Apr 03, 2025
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study.

Guillaume Cartron, Roch Houot, Yassine Al Tabaa

|May 14, 2024
Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.

Roch Houot, Emmanuel Bachy, Guillaume Cartron

|Dec 18, 2023
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.

Clémentine Sarkozy, Catherine Thieblemont, Lucie Oberic

|Oct 09, 2023
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.

Roch Houot, Emmanuel Bachy, Guillaume Cartron

Pageof 3

Frequent Collaborators

6 joint publications

Catherine Thieblemont

5 joint publications

Roch Houot

4 joint publications

Karin Tarte

4 joint publications

François-Xavier Gros